Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04720456Phase 2Completed
A Phase 2 trial of sonazoid in Portal Hypertension (PH), sponsored by Thomas Jefferson University. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04720456.